NasdaqGM - Delayed Quote USD

Kalaris Therapeutics, Inc. (KLRS)

3.4800
-0.3700
(-9.61%)
At close: May 9 at 4:00:01 PM EDT
3.4800
0.00
(0.00%)
After hours: May 9 at 4:05:13 PM EDT
Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
Total Revenue
0
0
0
Operating Expense
48,063
13,464
14,006
Operating Income
-48,063
-13,464
-14,006
Net Non Operating Interest Income Expense
-1,431
-687
-235
Other Income Expense
-1,118
-548
-1,244
Pretax Income
-50,612
-14,699
-15,485
Net Income Common Stockholders
-50,612
-14,699
-15,485
Diluted NI Available to Com Stockholders
-50,612
-14,699
-15,485
Total Operating Income as Reported
-48,063
-13,464
-14,006
Total Expenses
48,063
13,464
14,006
Net Income from Continuing & Discontinued Operation
-50,612
-14,699
-15,485
Normalized Income
-51,472
-15,006
-16,028
Interest Expense
1,431
687
235
Net Interest Income
-1,431
-687
-235
EBIT
-49,181
-14,012
-15,250
EBITDA
-49,181
-14,012
-15,250
Net Income from Continuing Operation Net Minority Interest
-50,612
-14,699
-15,485
Total Unusual Items Excluding Goodwill
860
307
543
Total Unusual Items
860
307
543
Normalized EBITDA
-50,041
-14,319
-15,793
Tax Rate for Calcs
0
0
0
Tax Effect of Unusual Items
0
0
0
12/31/2022 - 7/30/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers